Efficacy and safety of atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Junning Liu, Linfeng Yang, Wei Song, Jijiang Li, Pengsheng Yi
Topics & Concepts
AtezolizumabLenvatinibMedicineBevacizumabInternal medicineOncologyHazard ratioAdverse effectMeta-analysisHepatocellular carcinomaConfidence intervalCancerNivolumabChemotherapySorafenibImmunotherapyHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesCancer Mechanisms and Therapy